GEC-ESTRO recommendations for head & neck cancer brachytherapy (interventional radiotherapy): 2nd update with focus on HDR and PDR
Guinot, J. L. Bacorro, W. Budrukkar, A. Bussu, F. Gonzalez-Perez, V. Jaberi, R. Martinez-Monge, R. Rembielak, Anna Rovirosa, A Strnad, V.
Guinot, J. L.
Bacorro, W.
Budrukkar, A.
Bussu, F.
Gonzalez-Perez, V.
Jaberi, R.
Martinez-Monge, R.
Rembielak, Anna
Rovirosa, A
Strnad, V.
Citations
Altmetric:
Abstract
Modern brachytherapy (BT) is playing an important role in the multidisciplinary treatment of Head and Neck (H&N) cancer, as an organ- and function-preserving therapy. Low-dose-rate (LDR) technology has been replaced by modern remote afterloading and stepping source equipment using pulsed dose rate (PDR) or high dose rate (HDR) sources, improved image guidance and 3D treatment planning systems. This is an update of the previous GEC-ESTRO recommendations for H&N tumors, mainly applied to squamous carcinomas. Indications, results and recommended doses for different tumor sites are presented according to the published studies.
Description
Date
2024
Publisher
Collections
Keywords
Type
Article
Citation
Guinot JL, Bacorro W, Budrukkar A, Bussu F, Gonzalez-Perez V, Jaberi R, et al. GEC-ESTRO recommendations for head & neck cancer brachytherapy (interventional radiotherapy): 2nd update with focus on HDR and PDR. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2024 Dec;201:110533. PubMed PMID: 39284416. Epub 2024/09/17. eng.